drugset / Trial / NCT00020332

Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00020332

Phase 1/2 Completed National Cancer Institute (NCI)
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combination chemotherapy in treating patients who have locally advanced or metastatic breast cancer.

Timeline

Start
2000-10
Primary completion
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule Intravenous
Subject alvocidib Small molecule Intravenous

Indications